✦ LIBER ✦

Results of the treatment of children with recurrent gliomas with lomustine and vincristine

✍ Scribed by Ilene B. Lefkowitz; Roger J. Packer; Leslie N. Sutton; Kathy R. Siegel; Derek A. Bruce; Audrey E. Evans; Luis Schut

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 655 KB
Volume: 61
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880301)61:5<896::aid-cncr2820610507>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of treatment of children with re

Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine

✍ Ilene B. Lefkowitz; Roger J. Packer; Kathy R. Siegel; Leslie N. Sutton; Luis Sch 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

Primitive neuroectodermal tumors/medulloblastoma (PNET/MB) are the most common posterior fossa tumors in childhood. Despite surgery and radiation therapy, 40% to 50% of children with PNET/MB will have recurrent disease. Various chemotherapeutic agents are transiently effective in recurrent PNET/MB,

Successful treatment of low-grade oligod

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine

✍ Elize M. Biemond-ter Stege; Johan M. Kros; Hein G. de Bruin; R. H. Enting; Irene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Treatment of children with refractory ac

Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem

✍ Bessho, Fumio ;Kinumaki, Hiroshi ;Kobayashi, Miyuki ;Habu, Hiroshi ;Nakamura, Ka 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Dose-intensification of procarbazine, CC

Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas

✍ Jakacki, Regina I.; Jamison, Cheryl; Mathews, Vincent P.; Heilman, Douglas K.; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Background. The regimen of procarbazine, CCNU, and vincristine is active against gliomas. Previous attempts at dose-intensification have been unsuccesful because of delayed and cumulative myelosuppression. We sought to determine whether peripheral blood stem cell (PBSC) infusions would allow dose-es

A phase II study of topotecan with vincr

A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma

✍ Alberto Garaventa; Roberto Luksch; Simona Biasotti; Gianluca Severi; Maria Rosa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Background: A phase ii trial in children with advanced neuroblastoma was carried out in five italian institutions to evaluate the antitumor activity and tolerability of topotecan followed by vincristine and doxorubicin. ## Methods: Children older than age 1 year with stage iii or stage iv neur

Second-line treatment with carboplatin f

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy : A Phase II study

✍ Riccardo Soffietti; Mauro Nobile; Roberta Rudà; Marzia Borgognone; Alessandra Co 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## BACKGROUND The efficacy of second‐line chemotherapy for patients with recurrent or progressive oligodendroglial tumors is limited. In the current study, the authors investigated the use of carboplatin as a second‐line chemotherapeutic agent against these types of tumors. ## METHODS